There are no products listed under this category.
CYP2A13
CYP2A13 (cytochrome P450 family 2 subfamily A member 13, also known as CPAD or CYP2A) is a membrane-bound cytochrome P450 monooxygenase. It shows coumarin 7-hydroxylase activity and metabolically activates the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Browse Assay Genie's current range of CYP2A13 research reagents below, or read on for the biology behind the target.
CYP2A13 is a member of the cytochrome P450 superfamily, a group of monooxygenases that catalyse many reactions involved in drug metabolism and in the synthesis of cholesterol, steroids and other lipids. The enzyme exhibits coumarin 7-hydroxylase activity and also possesses phenacetin O-deethylation activity. It is active in the metabolic activation of several compounds, including hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone and N-nitrosomethylphenylamine.
A notable substrate is 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco and a recognised carcinogen. The CYP2A13 protein is metabolically active toward this compound, which is why it is often studied in the context of tobacco-related chemical activation. Although its endogenous substrate has not been determined, its xenobiotic activities are well described. The protein localises to the endoplasmic reticulum membrane and is found in the microsome membrane fraction, the usual location for P450 enzymes involved in drug and xenobiotic metabolism.
The CYP2A13 gene lies on chromosome 19q13.2, within a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies. HGNC places it in the cytochrome P450 family 2 gene group. Its earlier names include cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13, and the aliases CPAD and CYP2A. Neighbouring family members such as CYP2A6 and CYP2A7 are useful comparators when studying substrate specificity within the subfamily.
CYP2A13 metabolises compounds such as N,N-dimethylaniline and hexamethylphosphoramide, making it relevant to studies of how foreign chemicals are processed by P450 enzymes.
The enzyme is active in the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a focus for tobacco-related toxicology research.
Coumarin 7-hydroxylase and phenacetin O-deethylation activities provide defined reactions for characterising P450-mediated drug metabolism.
Located in a CYP2A, CYP2B and CYP2F gene cluster on chromosome 19q, CYP2A13 supports comparative work on related P450 genes.
CYP2A13 is a cytochrome P450 monooxygenase with coumarin 7-hydroxylase and phenacetin O-deethylation activity. It metabolically activates compounds including hexamethylphosphoramide, N,N-dimethylaniline and the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Its endogenous substrate has not been determined.
The HGNC name is cytochrome P450 family 2 subfamily A member 13, and UniProt calls the protein cytochrome P450 2A13. Aliases and previous symbols are CPAD and CYP2A. Older names include cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13.
The protein is located in the endoplasmic reticulum membrane and microsome membrane. The gene sits on chromosome 19q13.2 in a cluster of CYP2A, CYP2B and CYP2F genes. Mouse and rat orthologs are not specified here, so check the datasheet of any product for its validated reactivity.
Other CYP2A subfamily members, cytochrome P450 family 2 enzymes and xenobiotic-metabolising P450s with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16696; product specifications from Assay Genie datasheets.
There are no products listed under this category.